obesity drugs – Discover Pharma

Welcome to Discover Pharma! Today is : October 21, 2026

obesity drugs

Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development
Samsung Biologics to acquire PolyPeptide in $1.46bn deal
Samsung Biologics has announced plans to acquire peptide CDMO PolyPeptide [...]

July 21, 2026
Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Verdiva Bio unveils obesity drug data ahead of planned clinical entry
Verdiva Bio has reported new preclinical data for two obesity [...]

June 9, 2026
Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics
Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow
Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

May 5, 2026
Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas
23andMe study links genetics to GLP-1 weight loss outcomes and side effects
This Nature-published study from the 23andMe Research Institute identifies genetic [...]

May 5, 2026
Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics
Sharp invests $20m in US autoinjector and pen assembly to meet global injectables demand
Sharp is investing $20 million to expand autoinjector and pen [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK